1-14 of 14
Paul Moss, MBBS, PhD FRCP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib and Obinutuzumab in CLL: MRD Responses Sustained for Several Years with Deepest MRD Depletion in Patients with >1 Year Prior Ibrutinib Exposure

Andy C. Rawstron, PhD, Peter Hillmen, MBChB, FRCP, FRCPath, PhD, Shanna Maycock, BSc, MSc, Nichola Webster, Kristian Brock, PhD, Rebecca H. Boucher, BSc, MSc, PhD, Francesca Yates, PhD, Rebecca Jarvis, BSc, Surita Dalal, PhD, Ruth M. de Tute, PhD FRCPath, Paul Moss, MBBS, PhD FRCP, Donald Macdonald, MBChB, MD FRCP, PhD FCRPath, Piers Patten, MD PhD, Christopher Fegan, Andrew Pettitt, MA, MB BChir, PhD MRCP, MRCPath, Christopher P. Fox, MD PhD, Adrian Bloor, PhD FRCP, FRCPath, Oonagh Sheehy, MB BCh BAO, MRCP, FRCPath, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-136990
Published: 2020
Journal Articles

Low Numbers of CD27 - IgD - 'Double Negative' Senescent B-Cells Early after Reduced Intensity T Cell Depleted Haematopoietic Stem Cell Transplantation Are Predictive of Subsequent Chronic GvHD

Francesca Kinsella, PhD MRCP, FRCPath, Harriet Protheroe, MBChB BSc, Hayden Pearce, BSc. (Hons.), PhD, Charlotte F Inman, BVSc, PhD, Suzy A Eldershaw, BSc. (Hons.), PhD, Joanne Croudace, PhD, Ben E Abbotts, BSc. (Hons.), MSc., Jianmin Zuo, PhD, Ram K Malladi, FRCPath, Charles Craddock, FRCP, FRCPath, Paul Moss, MBBS, PhD FRCP
Journal: Blood
Blood (2019) 134 (Supplement_1): 4529.
https://doi.org/10.1182/blood-2019-131130
Published: 2019
Journal Articles

The Proportion of CD52/GPI Negative T Cells Early Following Alemtuzumab Conditioned Haematopoetic Stem Cell Transplantation Is an Independent Risk Factor for Acute GvHD

Francesca Kinsella, PhD MRCP, FRCPath, Charlotte F Inman, BVSc, PhD, Duncan Murray, FRCPath, MRCP, MA, BMBS, Wayne Croft, PhD, Jianmin Zuo, PhD, Hayden Pearce, BSc. (Hons.), PhD, Sara Barbieri, BSc MSc, Jane Nunnick, BSC. (Hons.), MSc., Sandeep Nagra, MBChB, Charles Craddock, FRCP, FRCPath, Ram K Malladi, FRCPath, Paul Moss, MBBS, PhD FRCP
Journal: Blood
Blood (2019) 134 (Supplement_1): 4543.
https://doi.org/10.1182/blood-2019-128292
Published: 2019
Journal Articles

Targeting an RNaseH2 Defect in Chronic Lymphocytic Leukaemia with PARP Inhibitors

Angelo Agathaggelou, Olga Murina, Andrew P Jackson, Paul Moss, MBBS, PhD FRCP, Shankara Paneesha, MD, Grant S Stewart, Malcolm Taylor, PhD, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1835.
https://doi.org/10.1182/blood-2018-99-115967
Published: 2018
Journal Articles

T Cell Versus T Cell; A Study of the Immune Checkpoint Landscape in Cutaneous T Cell Lymphoma

Duncan Murray, FRCPath, MRCP, MA, BMBS, Suzy A Eldershaw, BSc. (Hons.), PhD, Hayden Pearce, BSc. (Hons.), PhD, Nathaniel Davies, MSci, PhD, Jack McMurray, BSc, Julia J. Scarisbrick, MD FRCP, MBBS †, Paul Moss, MBBS, PhD FRCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 2754.
https://doi.org/10.1182/blood.V130.Suppl_1.2754.2754
Published: 2017
Journal Articles

BCR Unresponsiveness and 13q14 Duplication Underpin Spontaneous Disease Regression in Chronic Lymphocytic Leukemia

Marwan Kwok, MBBS,MRCP, Andy Rawstron, PhD, Angelo Agathanggelou, PhD, Anshita Goel, PhD, Ceri Oldreive, PhD, Rhiannon E Jones, PhD, Samantha Drennan, PhD, Archana Sharma-Oates, PhD, Paul Evans, PhD, Edward Smith, MSc, Jingwen Mao, Jamie Beaumont, Jusveen Rai, Mayumi Hamada, MB ChB, Surita Dalal, PhD, Naheema Gordon, MSc, Nicholas Davies, PhD, Helen Parry, MB ChB, MRCP, PhD, Andrew Beggs, MBBS, PhD FRCS, Talha Munir, Paul Moreton, MD MRCP, FRCPath, Shankara Paneesha, MD MRCP, FRCPath, Guy Pratt, MD FRCP, FRCPath, Malcolm Taylor, PhD, Francesco Forconi, MD DM, PhD FRCPath, Duncan M Baird, PhD, Jean-Baptiste Cazier, PhD, Paul Moss, MBBS, PhD FRCP, Peter Hillmen, MBChB, PhD, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3004.
https://doi.org/10.1182/blood.V130.Suppl_1.3004.3004
Published: 2017
Journal Articles

Vaccination with a DNA and MVA ‘Prime-Boost’ Regimen Induces Strong CD8 + T-Cell Responses Against the Immunodominant Minor Histocompatibility Antigen, HA-1: Results of a First-in-Man Phase I Clinical Trial

Charlotte F Inman, BVSc, PhD, Suzy A Eldershaw, BSc. (Hons.), PhD, Hayden Pearce, BSc. (Hons.), PhD, Ben E Abbotts, BSc. (Hons.), MSc., Mirjana Sirovica, BSc(Hons), MSc, Paul Ferguson, MD PhD MRCP, Donna L Walsh, Dip(HE), BSc., Jane Nunnick, BSC. (Hons.), MSc., Shamyla Siddique, BSc.(Hons.), MPhil, Paul Moss, MBBS, PhD FRCP, Ram K Malladi, FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 1908.
https://doi.org/10.1182/blood.V130.Suppl_1.1908.1908
Published: 2017
Journal Articles

NK Cells Produce High Levels of IL-10 Early after Allogeneic Stem Cell Transplantation and Suppress Development of Acute GVHD

Paul Moss, MBBS, PhD FRCP, Ram Malladi, MRCP, FRCPath, PhD, Tracey Chan, PhD, Jianmin Zuo, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5489.
https://doi.org/10.1182/blood.V130.Suppl_1.5489.5489
Published: 2017
Journal Articles

Chronic Lymphocytic Leukaemia Drives the Production of T Regulatory Cells From the CD4+ CD25- Compartment with a CD27high/CD127 Low Phenotype.

Karen Piper, Mamtha Karanth, Doctor, Andrew McLarnon, Emma Kalk, Naeem Khan, Jim A Murray, Guy Pratt, Paul Moss, MBBS, PhD, FRCP
Journal: Blood
Blood (2009) 114 (22): 2330.
https://doi.org/10.1182/blood.V114.22.2330.2330
Published: 2009
Journal Articles

Large Scale Screening for DNA Damage-Induced Transcription Factors as Potential Targets for Treatment of CLL with p53 Apoptotic Defect.

Victoria Weston, PhD, Paul Moss, MBBS, PhD, FRCP, A. Malcolm R Taylor, PhD, Tatjana Stankovic, MD., PhD
Journal: Blood
Blood (2009) 114 (22): 3439.
https://doi.org/10.1182/blood.V114.22.3439.3439
Published: 2009
Journal Articles

Increased Frequency of Constitutional Pathogenic ATM Mutations in CLL Patients Compared to Control Individuals Suggests An Aetiological Role.

Tatjana Stankovic, MD.PhD, Belinda Austen, Guy Pratt, Anna Skowronska, David Oscier, Martin JS Dyer, Estella Matutes, MD, PhD, Malcolm Taylor, Paul Moss, MBBS, PhD, FRCP
Journal: Blood
Blood (2009) 114 (22): 1250.
https://doi.org/10.1182/blood.V114.22.1250.1250
Published: 2009
Journal Articles

The Epigenetic Therapies Azacitidine and Sodium Valproate Augment Immune Responses to the MAGE Cancer Testis Antigen in Acute Myeloid Leukemia and Myeloma.

Oliver Charles Goodyear, PhD, Angelo Agathanggelou, PhD, Gordon Ryan, Igor Novitsky-Basso, Tatjana Stankovic, MD., PhD, Paul Moss, MBBS, PhD, FRCP, Charles F. Craddock, BM, MRCP, MRCPath
Journal: Blood
Blood (2009) 114 (22): 2086.
https://doi.org/10.1182/blood.V114.22.2086.2086
Published: 2009
Journal Articles

Defect in DNA Double Strand Break Response in Paediatric ALL Is Caused by Upregulation of Multiple Pro-Survival Pathways That Can Serve as Therapeutic Targets.

Tatjana Stankovic, MD., PhD, Eliot Marston, Victoria Weston, Angelo Agathanggelou, Katie Mapp, Pamela Kearns, Francesco Falciani, Paul Moss, MBBS, PhD, FRCP, Malcolm Taylor
Journal: Blood
Blood (2008) 112 (11): 3344.
https://doi.org/10.1182/blood.V112.11.3344.3344
Published: 2008
Journal Articles

Epigenetic Manipulation of Cancer Testis Antigen (CTA) Expression: A Strategy for Manipulating the Graft-Versus Leukaemia Response in Patients Allografted for Haematological Malignancies

Tatjana Stankovic, MD., Andrew McLarnon, Angelo Agathanggelou, Oliver Goodyear, Charles Craddock, Paul Moss, MBBS, PhD, FRCP
Journal: Blood
Blood (2008) 112 (11): 600.
https://doi.org/10.1182/blood.V112.11.600.600
Published: 2008